+86-28-82633987
ISO ISO
ISO 17025 ISO 17025
usp usp
EN
CN EN

Swertiamarin

BP1349
17388-39-5
98%
Biopurify
Swertia bimaculata
Swertiamarin possesses anti-hyperglycemic, anti-hyperlipidemic, anti-diabetic activity and enhances β cell regeneration which causes reversal of diabetes. Swertiamarin also possesses significant wound healing, anti-inflammatory, antioxidant, hepatoprotective, peripheral and central antinociceptive properties. Swertiamarin inhibits the development of arthritis by modulating NF-κB/IκB and JAK2/STAT3 signaling, it acts as an anti-rheumatic agent.
Catalog No Package Original Price Price Inventory Quantity Operating
BP1349-20mg 20mg
BP1349-100mg 100mg
BP1349-1000mg 1000mg
Chengdu Biopurify Phytochemicals Ltd.
Chengdu Biopurify Phytochemicals Ltd.

Related targets

PTPN1 NFE2L2 TNF NR3C1 NFKB1 PPARA
PTPN1 STAT3 NFE2L2 TNF NFKB1 TGFB1 FASN ACTA2 PPARA
STAT3 NFE2L2 TNF NFKB1 TGFB1 MMP3 JAK2

Product drug property prediction parameters

  • 155.1400

  • -1.5760

  • -1.5755

  • 44.7294

  • .5041

  • .4922

  • Low

  • 31.5644

  • 5.0104

  • Yes

  • No

  • No

  • No

  • Yes

  • No

  • 0.0

  • Yes

  • Yes

  • Yes

  • Yes

Product documentation Product documentation